Kouroupis, D.; Zografou, I.; Doukelis, P.; Patoulias, D.; Popovic, D.S.; Karakasis, P.; Pyrpasopoulou, A.; Stavropoulos, K.; Papadopoulos, C.; Giouleme, O.;
et al. Presepsin: An Emerging Biomarker in the Management of Cardiometabolic Disorders. J. Pers. Med. 2025, 15, 125.
https://doi.org/10.3390/jpm15040125
AMA Style
Kouroupis D, Zografou I, Doukelis P, Patoulias D, Popovic DS, Karakasis P, Pyrpasopoulou A, Stavropoulos K, Papadopoulos C, Giouleme O,
et al. Presepsin: An Emerging Biomarker in the Management of Cardiometabolic Disorders. Journal of Personalized Medicine. 2025; 15(4):125.
https://doi.org/10.3390/jpm15040125
Chicago/Turabian Style
Kouroupis, Dimitrios, Ioanna Zografou, Panagiotis Doukelis, Dimitrios Patoulias, Djordje S. Popovic, Paschalis Karakasis, Athina Pyrpasopoulou, Konstantinos Stavropoulos, Christodoulos Papadopoulos, Olga Giouleme,
and et al. 2025. "Presepsin: An Emerging Biomarker in the Management of Cardiometabolic Disorders" Journal of Personalized Medicine 15, no. 4: 125.
https://doi.org/10.3390/jpm15040125
APA Style
Kouroupis, D., Zografou, I., Doukelis, P., Patoulias, D., Popovic, D. S., Karakasis, P., Pyrpasopoulou, A., Stavropoulos, K., Papadopoulos, C., Giouleme, O., Kotsa, K., Doumas, M., & Koufakis, T.
(2025). Presepsin: An Emerging Biomarker in the Management of Cardiometabolic Disorders. Journal of Personalized Medicine, 15(4), 125.
https://doi.org/10.3390/jpm15040125
